DaVita Inc. Common Stock · Transaction Mar 27, 2026 · Filed Jul 21, 2026 · $1,001 to $15,000
DaVita Inc
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is DVA moving today?
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
DVA overview
Related filings and maps
Congress activity in DVA
DaVita Inc. Common Stock · Transaction Sep 25, 2025 · Filed Oct 7, 2025 · $1,001 to $15,000
DVA Common Stock · Transaction Sep 5, 2025 · Filed Oct 3, 2025 · Amount pending receipt enrichment
DVA Common Stock · Transaction May 28, 2025 · Filed Jun 10, 2025 · Amount pending receipt enrichment
DaVita Inc. Common Stock · Transaction Dec 14, 2023 · Filed Jan 17, 2024 · $1,001 to $15,000
DVA contract awards, year to date.
Public federal awards linked to this ticker.
DVA lobbying filings, year to date.
Registered lobbying filings matched to DaVita Inc.
DAVITA INC.
DAVITA INC.
DAVITA INC.